Skip to main content

Table 5 Adverse events after GSMs-TACE treatment (n = 27)

From: Clinical application of gelatin sponge microparticles combined with pirarubicin for hepatic transcatheter arterial chemoembolization in breast cancer liver metastasis treatment: results of a single-center long-term study

Adverse events

Level 1

Level 2

Level 3

Level 4

Fever

15

5

1

0

Pain

13

2

1

0

Nausea and vomiting

7

2

1

0

Abscess

0

0

0

0

Cholecystitis

2

0

0

0

Pancreatitis

0

0

0

0

Renal insufficiency

1

0

0

0

Hepatic insufficiency

20

6

1

0

Bone marrow arrest

2

1

0

0